BG Stock Surges 18% With A 6-day Winning Spree On BofA Target Hike
Bunge Global (BG) – a producer of sugar, ethanol, flours, and bioenergy products – hit 6-day winning streak, with cumulative gains over this period amounting to a 18%. The company market cap has surged by about $3.2 Bil over the last 6 days, and currently stands at $21 Bil.
The stock has YTD (year-to-date) return of 22.2% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity, or a trap.
What Triggered The Rally?
[1] BofA Securities Price Target Hike to $119
- Maintained ‘Buy’ Rating
- Confidence in Viterra Merger Synergies
- Impact: Stock Hit New 52-Week High, Sustained Institutional Accumulation
Opportunity or Trap?
Below is our take on valuation.
There are several things to fear in BG stock given its overall Weak operating performance and financial condition. This is aligned with the stock’s Low valuation because of which we think it is Fairly Priced (For details, see Buy or Sell BG).
But here is the real interesting point.
You are reading about this 18% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that haven not surged yet.
Returns vs S&P 500
The following table summarizes the return for BG stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | BG | S&P 500 |
|---|---|---|
| 1D | 3.2% | 0.3% |
| 6D (Current Streak) | 17.5% | 0.3% |
| 1M (21D) | 17.5% | 1.9% |
| 3M (63D) | 17.8% | 4.1% |
| YTD 2026 | 22.2% | 1.4% |
| 2025 | 18.6% | 16.4% |
| 2024 | -20.7% | 23.3% |
| 2023 | 3.8% | 24.2% |
However, big gains can follow sharp reversals – but how has BG behaved after prior drops? See BG Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 113 S&P constituents with 3 days or more of consecutive gains and 47 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 32 | 20 |
| 4D | 38 | 14 |
| 5D | 5 | 7 |
| 6D | 34 | 5 |
| 7D or more | 4 | 1 |
| Total >=3 D | 113 | 47 |
Key Financials for Bunge Global (BG)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $59.5 Bil | $53.1 Bil |
| Operating Income | $3.1 Bil | $1.6 Bil |
| Net Income | $2.2 Bil | $1.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $12.8 Bil | $22.2 Bil |
| Operating Income | $320.0 Mil | $385.0 Mil |
| Net Income | $354.0 Mil | $166.0 Mil |
While BG stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.